1. Li, Huimeng, Zhang, Hengyu, Tan, Xin, Liu, Rui, Tang, Shicong. 2021. Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer. In Experimental and therapeutic medicine, 22, 699. doi:10.3892/etm.2021.10131. https://pubmed.ncbi.nlm.nih.gov/34007308/
2. Nabbi, Arash, McClurg, Urszula L, Thalappilly, Subhash, Binda, Olivier, Riabowol, Karl T. 2017. ING3 promotes prostate cancer growth by activating the androgen receptor. In BMC medicine, 15, 103. doi:10.1186/s12916-017-0854-0. https://pubmed.ncbi.nlm.nih.gov/28511652/
3. Chen, G, Wang, Y, Garate, M, Zhou, J, Li, G. 2009. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system. In Oncogene, 29, 1498-508. doi:10.1038/onc.2009.424. https://pubmed.ncbi.nlm.nih.gov/19935701/
4. Cheng, Shiliang, Li, Meng, Zheng, Wen, Zhuo, Jinhua, Zhang, Lu. 2024. ING3 inhibits the malignant progression of lung adenocarcinoma by negatively regulating ITGB4 expression to inactivate Src/FAK signaling. In Cellular signalling, 117, 111066. doi:10.1016/j.cellsig.2024.111066. https://pubmed.ncbi.nlm.nih.gov/38281617/